tadalafil has been researched along with Anterior Choroidal Artery Infarction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gulati, P; Singh, N | 2 |
2 other study(ies) available for tadalafil and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
Neuroprotective effect of tadalafil, a PDE-5 inhibitor, and its modulation by L-NAME in mouse model of ischemia-reperfusion injury.
Topics: Animals; Carbolines; Cerebral Infarction; Male; Memory; Mice; Motor Activity; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Phosphodiesterase 5 Inhibitors; Reperfusion Injury; Tadalafil | 2014 |
Tadalafil enhances the neuroprotective effects of ischemic postconditioning in mice, probably in a nitric oxide associated manner.
Topics: Animals; Ataxia; Brain; Brain Ischemia; Carbolines; Cerebral Infarction; Cyclic Nucleotide Phosphodiesterases, Type 5; Ischemic Postconditioning; Male; Memory Disorders; Mice; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Phosphodiesterase 5 Inhibitors; Reperfusion Injury; Tadalafil | 2014 |